NCP112

Huons Co., Ltd. · Phase 1 active Small molecule

At a glance

Generic name	NCP112
Sponsor	Huons Co., Ltd.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Clinical Study for the Evaluation of Safety and Tolerability of NCP112 Eye Drops (PHASE1)
A Single-center, Randomized, Double-blinded, Placebo-controlled, Phase 1 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of NCP112 (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

NCP112 CI brief — competitive landscape report
NCP112 updates RSS · CI watch RSS
Huons Co., Ltd. portfolio CI